Stockscreener 앱 받기
40.76
1.29%
0.4912
전일 마감가:
$40.27
열려 있는:
$40.83
하루 거래량:
1.08M
Relative Volume:
0.47
시가총액:
$7.67B
수익:
$550.17M
순이익/손실:
$201.35M
주가수익비율:
40.76
EPS:
1
순현금흐름:
$232.07M
1주 성능:
-6.74%
1개월 성능:
-8.65%
6개월 성능:
-34.26%
1년 성능:
-22.99%
1일 변동 폭
$40.25
$41.49
1주일 범위
$39.95
$45.17
52주 변동 폭
$39.95
$85.21
Doximity Inc Stock (DOCS) Company Profile
명칭
Doximity Inc
전화
(650) 549-4330
주소
500 THIRD STREET, SUITE 510, SAN FRANCISCO
DOCS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
DOCS
Doximity Inc
|
40.75 | 7.58B | 550.17M | 201.35M | 232.07M | 1.00 |
|
VEEV
Veeva Systems Inc
|
219.53 | 35.98B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
70.54 | 12.33B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
HQY
Healthequity Inc
|
88.63 | 7.31B | 1.15B | 96.70M | -161.99M | 1.09 |
|
BTSG
Brightspring Health Services Inc
|
39.50 | 6.93B | 11.99B | 24.18M | 234.31M | 0.2956 |
Doximity Inc Stock (DOCS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-09 | 개시 | RBC Capital Mkts | Outperform |
| 2026-01-08 | 업그레이드 | Truist | Hold → Buy |
| 2025-12-15 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2025-12-09 | 개시 | Barclays | Overweight |
| 2025-11-21 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2025-11-13 | 개시 | BMO Capital Markets | Market Perform |
| 2025-10-27 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2025-10-10 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2025-10-01 | 다운그레이드 | Goldman | Neutral → Sell |
| 2025-07-09 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2025-06-02 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2025-02-07 | 업그레이드 | Leerink Partners | Market Perform → Outperform |
| 2025-02-07 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2024-12-20 | 개시 | Stephens | Equal-Weight |
| 2024-12-04 | 개시 | Mizuho | Neutral |
| 2024-11-15 | 개시 | Goldman | Neutral |
| 2024-11-14 | 업그레이드 | Morgan Stanley | Underweight → Equal-Weight |
| 2024-11-13 | 다운그레이드 | Canaccord Genuity | Buy → Hold |
| 2024-11-08 | 업그레이드 | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2024-11-08 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2024-10-15 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2024-08-09 | 업그레이드 | Needham | Hold → Buy |
| 2024-07-18 | 다운그레이드 | Wells Fargo | Equal Weight → Underweight |
| 2024-04-25 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2024-02-26 | 개시 | Leerink Partners | Market Perform |
| 2024-01-03 | 개시 | Barclays | Equal Weight |
| 2024-01-02 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2023-08-09 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2023-08-09 | 다운그레이드 | Needham | Buy → Hold |
| 2023-08-03 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2023-05-01 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2023-01-06 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2022-10-31 | 개시 | Wells Fargo | Overweight |
| 2022-10-24 | 개시 | Evercore ISI | In-line |
| 2022-10-13 | 개시 | BTIG Research | Neutral |
| 2022-09-16 | 개시 | KeyBanc Capital Markets | Sector Weight |
| 2022-09-07 | 개시 | Truist | Hold |
| 2022-08-05 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2022-07-28 | 개시 | Berenberg | Buy |
| 2022-05-18 | 재확인 | BofA Securities | Neutral |
| 2022-05-18 | 재확인 | Goldman | Buy |
| 2022-05-18 | 재확인 | Guggenheim | Buy |
| 2022-05-18 | 재확인 | Jefferies | Buy |
| 2022-05-18 | 재확인 | Morgan Stanley | Equal-Weight |
| 2022-05-18 | 재확인 | Needham | Buy |
| 2022-04-07 | 개시 | Guggenheim | Buy |
| 2022-04-04 | 개시 | BofA Securities | Neutral |
| 2022-02-11 | 개시 | Goldman | Buy |
| 2021-12-14 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2021-12-02 | 개시 | Jefferies | Buy |
| 2021-11-17 | 개시 | Robert W. Baird | Outperform |
| 2021-11-10 | 재확인 | Canaccord Genuity | Buy |
| 2021-11-10 | 재확인 | Goldman | Neutral |
| 2021-11-10 | 재확인 | Morgan Stanley | Equal-Weight |
| 2021-11-10 | 재확인 | Needham | Buy |
| 2021-11-10 | 재확인 | Piper Sandler | Overweight |
| 2021-08-26 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2021-07-19 | 개시 | Canaccord Genuity | Buy |
| 2021-07-19 | 개시 | Goldman | Neutral |
| 2021-07-19 | 개시 | JP Morgan | Overweight |
| 2021-07-19 | 개시 | Morgan Stanley | Equal-Weight |
| 2021-07-19 | 개시 | Piper Sandler | Overweight |
| 2021-07-19 | 개시 | Raymond James | Outperform |
| 2021-07-19 | 개시 | SVB Leerink | Outperform |
| 2021-07-19 | 개시 | William Blair | Outperform |
모두보기
Doximity Inc 주식(DOCS)의 최신 뉴스
Raymond James sees ‘knee-jerk’ AI reaction, reaffirms strong buy on Doximity, Inc. (DOCS) - MSN
Raymond James Sees ‘Knee-Jerk’ AI Reaction, Reaffirms Strong Buy on Doximity, Inc. (DOCS) - Yahoo Finance
Bandwidth, Dynatrace, Paylocity, Doximity, and Agilysys Stocks Trade Down, What You Need To Know - TradingView — Track All Markets
Redlands Daily Facts - FinancialContent
3 Reasons DOCS Has Explosive Upside Potential - Finviz
Is Doximity (DOCS) Pricing Reflect Its Mixed Valuation Signals After Recent Share Price Slide - Yahoo Finance
Doximity (DOCS) Declines More Than Market: Some Information for Investors - sharewise.com
Winners Losers: Will Doximity Inc stock reach Wall Street targetsJuly 2025 Intraday Action & Risk Controlled Daily Trade Plans - Bộ Nội Vụ
Here's Why Doximity (DOCS) is a Strong Growth Stock - sharewise.com
Doximity (NASDAQ:DOCS) Sets New 1-Year LowWhat's Next? - MarketBeat
Here Are Monday’s Top Wall Street Analyst Research Calls: Doximity, KB Home, NVIDIA, Okta, On Holdings, Take-Two Interactive, Vail Resorts, and More - AOL.com
Ad Vital Founder Dr. Shitel Patel Featured in Doximity For Expertise on Practice Sustainability - Digital Journal
Penticton Herald: FinanceDoximity (DOCS) Shares Hit 52-Week Low: Analyzing the Digital Health Downturn - FinancialContent
Doximity stock hits 52-week low at 43.17 USD By Investing.com - Investing.com Nigeria
Doximity stock hits 52-week low at 43.17 USD - Investing.com
Doximity (DOCS) Slid on Renewed Volatility - Yahoo Finance
As layoff loomed, exec turned to insider trading - Investment Executive
Doximity, Inc. (DOCS) Stock Analysis: Evaluating the 49% Potential Upside in Healthcare’s Digital Frontier - DirectorsTalk Interviews
Volatility Watch: Will Doximity Inc stock benefit from upcoming earnings reportsOptions Play & Safe Entry Trade Reports - Bộ Nội Vụ
InvestingPro’s Fair Value model predicted Doximity’s 41% stock decline By Investing.com - Investing.com UK
Doximity reaches $31M settlement in securities litigation lawsuit - MSN
Understanding Momentum Shifts in (DOCS) - Stock Traders Daily
Morgan Stanley views Doximity (DOCS) underperformance as attractive entry point amid strong engagement - MSN
Morgan Stanley Views Doximity (DOCS) Underperformance as Attractive Entry Point Amid Strong Engagement - Insider Monkey
Doximity, Inc. (NYSE:DOCS) Given Consensus Rating of "Buy" by Analysts - MarketBeat
Doximity (NYSE:DOCS) Stock Rating Upgraded by The Goldman Sachs Group - MarketBeat
Doximity (NYSE:DOCS) Raised to "Strong-Buy" at Truist Financial - MarketBeat
Morgan Stanley Stays Neutral on Doximity, Highlights Strength in Video Module Business - MSN
Doximity (NYSE:DOCS) Stock Rating Lowered by Wall Street Zen - MarketBeat
Ex-Doximity Exec Cops To $2.5M Insider Trading Scheme - Law360
Doximity: RBC touts growth moat while Goldman sees valuation reset - Investing.com
Doximity's Double-Digit Growth Rate is Sustainable, RBC Says - marketscreener.com
Will Doximity’s (DOCS) AI Momentum and US$31 Million Settlement Shift Its Core Investment Narrative? - Yahoo Finance
Raymond James reiterates Strong Buy on Doximity stock amid AI competition - Investing.com Nigeria
Can Doximity Inc. stock outperform in 2025 bull market2025 Growth vs Value & Capital Protection Trade Alerts - ulpravda.ru
How Doximity Inc. stock reacts to global recession fearsEarnings Trend Report & AI Enhanced Trading Signals - ulpravda.ru
Doximity stock initiated with Outperform rating by RBC Capital - Investing.com UK
Toast, GitLab, Doximity, Commvault, and Braze Stocks Trade Down, What You Need To Know - Finviz
Doximity stock initiated with Outperform rating by RBC Capital By Investing.com - Investing.com Nigeria
Assessing Doximity (DOCS) Valuation After Volatile Trading And Recent AI Product Updates - Yahoo Finance
Is Doximity Inc. stock attractive for long term wealth building2025 Pullback Review & Reliable Trade Execution Plans - ulpravda.ru
Is Doximity Inc. stock attractive for ETFs2025 Sector Review & Free Risk Controlled Daily Trade Plans - ulpravda.ru
Raymond James sees strong growth for Doximity stock amid stable pharma budgets By Investing.com - Investing.com South Africa
Raymond James sees strong growth for Doximity stock amid stable pharma budgets - Investing.com Nigeria
Will Doximity Inc. stock benefit from upcoming earnings reports2025 Buyback Activity & Risk Managed Trade Strategies - ulpravda.ru
Will Doximity Inc. stock keep outperforming rivalsWeekly Risk Report & Risk Controlled Swing Trade Alerts - ulpravda.ru
Doximity Inc (DOCS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.67%
자본화:
|
볼륨(24시간):